Leminorella is proposed as a new genus for the group of Enterobacteriaceae formerly known as Enteric Group 57. Strains of Leminorella gave positive tests for H2S production, acid production from L-arabinose and D-xylose, and tyrosine clearing; they were negative for indole production, Voges-Proskauer, urea hydrolysis, phenylalanine deaminase, motility, gelatin liquefaction, lysine and ornithine decarboxylases, arginine dihydrolase, growth in KCN, and acid production from adonitol, D-arabitol, cellobiose, erythritol, D-galactose, myo-inositol, lactose, maltose, D-mannitol, D-mannose, melibiose, a-CH3-glucoside, raffinose, L-rhamnose, salicin, D-sorbitol, sucrose, and trehalose. By DNA hybridization, strains of Leminorella were only 3 to 16% related to other Enterobacteriaceae and were divided into three groups. Leminorella grimontii is proposed as the type species for the genus and strain CDC 1944-81, ATCC 33999, is designated as the type strain. There were four strains of L. grimontii from stool specimens and two from urine specimens. L. richardii is proposed as the name for the second species (type strain, CDC 0978-82, ATCC 33998). All four L. richardii strains were from stool specimens. L. grimontii can be distinguished from L. richardii because it produces gas from glucose (100%) and acid from dulcitol (83%) and is methyl red positive (100%). One strain, CDC 3346-72, was more related to L. grimontii by DNA hybridization than to L. richardii, but the lower relatedness to both of these species indicated that it may be a third species. Biochemically it could not be distinguished from L. grimontii. All Leminorella strains were resistant (no zone of inhibition) to ampicillin, carbenicillin, and cephalothin.
The vernacular name "Enteric Group 57" was first coined in 1981 when a diagnostic strain was being studied. A computer search of the records of the Enteric Bacteriology Section, Centers for Disease Control, revealed nine similar isolates (Table 1 ). An additional isolate was found in 1982. These isolates produced H2S in triple sugar iron agar, but were otherwise relatively inactive biochemically ( Table 2) . Some of them had been sent to us as Salmonella, and two reacted weakly in Salmonella antisera ( Table 1 ). The name Enteric Group 57 was used until these strains could be studied further and a better classification could be proposed. The purpose of this paper is to show that Enteric Group 57 strains belong in a new genus in the Family Enterobacteriaceae. We propose Leminorella as a new genus and Leminorella grimontii and L. richardii as two species.
MATERIALS AND METHODS Bacterial strains. Eleven strains identified as Enteric Group 57 were studied (Table 1 ). All strains were maintained on semisolid Trypticase soy agar (BBL Microbiology Systems, Cockeysville, Md.) at room temperature (18 to 28°C) and were also frozen in 10% skim milk and maintained at -70°C. This semisolid medium contained the following: Trypticase * Corresponding author. peptone (BBL), 15 g; phytone peptone, 5 g; sodium chloride, 5 g; agar, 4 g; and distilled water, 1,000 ml. All incubations were at 36 ± 1°C unless otherwise noted.
Media and biochemical tests. Commercial media were used whenever possible. The biochemical tests listed in Table 2 were done by the methods of Edwards and Ewing (5) , with some modifications as previously described (10, 11) .
DNA relatedness. DNA relatedness was determined for the 11 Enteric Group 57 strains listed in Table 3 . Unlabeled DNA was isolated and purified by methods previously described (3, 4) . DNA from strain 1944-81 (ATCC 33999) was labeled first in vitro with 32PO4 by nick translation essentially by the methods of Rigby et al. (19) Description of Leminorella. We propose the genus name Leminorella for the group of strains formerly referred to as Enteric Group 57. The generic name is derived from the surname of Leon Le Minor, a French microbiologist, and was chosen to honor him for his many contributions to enteric bacteriology. At the Pasteur Institute, Paris, he has worked to clarify the nomenclature and serology of Salmonella, has described many new serotypes, and has done studies on a wide variety of topics in enteric bacteriology including lysogeny, metabolic plasmids, and new and rapid biochemical tests (12) (13) (14) . Leminorella also honors Simone Le Minor, wife and colleague of Leon Le Minor, who has also made many contributions to enteric bacteriology as head of the National Salmonella Centre of France and with her research on Serratia serology (13, 15) . Leminorella (pronounced LU-mean-nohr-rel'-la) is a neo (modern) Latin feminine noun formed by adding the diminutive ending "-ella" to the noun Le Minor. Strains of Leminorella have the general properties of the family Enterobacteriaceae (Table 2) . They are unique in that they give positive tests for H2S production, acid production from L-arabinose and Dxylose, and tyrosine clearing, but are otherwise rather inactive (Table 2) . They are resistant (no zone of inhibition) to ampicillin, carbenicillin, and cephalothin. A complete description of the genus and its species is given in Tables 2   through 6 .
Description of L. grimontii. The name L. grimontii (pronounced gree-mohn'-tee-eye) is proposed for the first DNA hybridization group and is proposed as the type species for the genus. This species name is derived from the surname of Patrick Grimont, a French microbiologist at the Pasteur Institute, and for his wife and colleague, Francine Grimont. They have done definitive work on the genus Serratia, described new species of Enterobacteriaceae, and studied enteric bacteria phenetically and genetically (6-9). The species name is treated as a modern Latin genitive noun meaning "of Grimont." The type strain for this species is designated as CDC 1944-81 (ATCC 33999).
Description of L. richardii. The name L. richardii (pronounced ri-shar'-dee-eye) is proposed for the second DNA hybridization group. This name was chosen to honor Claude Richard, who is also a French microbiologist at Pasteur Institute, for his studies on the biochemical characterization of Enterobacteriaceae and the description of new species (16) (17) (18) . This species name is also treated as a modern Latin genitive noun meaning "of Richard." Strain 0978-82 (ATCC 33998) is designated as the type strain. L. grimontii can be differentiated from L. richardii because it produces gas from D-glucose (100%) and acid from dulcitol (83%) and is methyl red positive (100% acid from D-glucose until 48 h. In addition, some of the strains grew poorly when taken from stock cultures. We therefore recommend freezing these strains for long-term maintenance. When biochemical tests were repeated on the two type strains and 3346-72 at 25°C, the reactions were not improved; some were even weaker. They were not motile at 250C.
Strains of Leminorella should be easy to recognize. They are H2S positive, D-mannose negative, and tyrosine positive much like Proteus species, but they are also urea negative, phenylalanine negative, and L-arabinose positive. They are susceptible to colistin, but have no zone of inhibition around penicillin, ampicillin, carbenicillin, and cephalothin. On primary plating media, Leminorella strains appear as lactosenegative colonies. Within 48 h in triple sugar iron agar, they give an alkaline slant and a weak acid reaction in the butt with H2S production. Gas production in D-glucose, a positive methyl red test, and acid production in dulcitol by L. grimontii separate it from L. richardii. We hope this paper will stimulate others to isolate and identify these organisms.
We are sometimes asked the question, "Why name a new genus or species on the basis of a few strains of unknown clinical significance?" The first step in learning more about an organism is to give it a scientific name. Whenever possible, new organisms are classified in existing genera; however, many of the newly discovered organisms have been different from all existing genera both by phenotype and by molecular techniques (3, 8) . Our purpose in naming a new organism is not to create a burden for clinical microbiologists, but to provide a simple means of communicating about an entity found in the laboratory. The best method of Legion- ella, and several other new organisms indicates that some will be important in human disease. However, it is also important to know that an organism is not clinically significant in certain segments of the human population or at certain body sites. It is too early to evaluate the clinical significance of Leminorella. We hope that this report will begin the process of learning more about it.
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